A drug-delivery solution provider, ZIM Laboratories Limited develops and manufactures innovative, differentiated pharmaceutical products targeting patient convenience and adherence.
ZIM Corporate Film
Latest News & Events
CPhI Worldwide Show Daily
Five minutes with Nidhi Sapkal, principal research coordinator, Zim laboratories.
What are the current global trends driving in the pharmaceutical sector you are working in? How does your company respond to those trends?
ZIM can now manufacture and market Rizatriptan Orally Disintegrating Strips
Rizatriptan Orally Disintegrating Strips, a treatment for migraine headache can now be manufactured and marketed by ZIM Laboratories Limited. Rizatriptan Orally Disintegrating Strips will be very helpful for migraine patients who find it difficult to swallow medicines during migraine attacks.
We are the first Indian company to get this approval from the Central Drugs Standard Control Organization, India (CDSCO).
ZIM is now a Three Star Export House Certified Company.
ZIM Laboratories Limited has been certified as a Three Star Export House Company by Foreign Trade Policy, 2015-2020. The certificate is valid for the time span of five years, i.e., from 29th July 2017 to 28th July 2021.
Adding another feather to the accomplishments of ZIM, the company can now explore the benefits subject to the conditions prescribed in Para 3.20 (b) of the Hand Book of Procedures (2015-2020).
Express Pharma and the India Express group hosted the Inaugural edition of FDD Conclave Awards for the year 2017 at Hyderabad.The most prestigious awards was attended by 100 leading scientists and R&D heads representing prominent pharma organisation and top biotech companies.The FDD Leadership Awards was a power packed event well organized with motivational speeches and scientific sessions.
Nagpur-based pharmaceutical company ZIM Laboratories sensed the need to develop novel drug delivery systems (NDDS) at a time when India is seeing a significant rise in its number of children as well as geriatrics.
The need for a multidisciplinary approach to deliver greater therapeutic results has opened new avenues for growth in the novel drug delivery systems market. In this issue, Express Pharma profiles two upcoming companies, that have chosen niche formulations to chart their success stories.
ZIM Laboratories Limited is proud to announce its collaboration with prestigious “Institute of Chemical Technology”, Mumbai. In line with its motto of “Zeal and Innovation in Medicine”, ZIM Laboratories Limited is sponsoring Mr. Darsheen Kotak, a Doctoral research student from ICT, to work on a research project in the area of “Design and Development of Non-invasive Drug Delivery System for Large Molecules”.